Granular tau oligomers as intermediates of tau filaments

Biochemistry

Volumn 46, Issue 12, 2007, Pages 3856-3861

  Maeda, Sumihiro ^a   Sahara, Naruhiko ^a   Saito, Yuko ^b   Murayama, Miyuki ^a   Yoshiike, Yuji ^a   Kim, Hyonchol ^c,d   Miyasaka, Tomohiro ^a   Murayama, Shigeo ^b   Ikai, Atsushi ^c   Takashima, Akihiko ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CONFORMATIONS; DISEASES; NEUROLOGY; PATHOLOGY; PROTEINS; SPECTRUM ANALYSIS;

ALZHEIMER'S DISEASE (AD); FIBRIL FORMATION; NEUROFIBRILLARY TANGLES (NFT); PAIRED HELICAL FILAMENTS (PHF);

OLIGOMERS;

OLIGOMER; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; ATOMIC FORCE MICROSCOPY; BRAIN TISSUE; CIRCULAR DICHROISM; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE MARKER; EARLY DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NEUROFIBRILLARY TANGLE; PAIRED HELICAL FILAMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; TAUOPATHY;

AGING; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN CHEMISTRY; CIRCULAR DICHROISM; FRONTAL LOBE; HUMANS; MICROSCOPY, ATOMIC FORCE; NEUROFIBRILLARY TANGLES; TAU PROTEINS;

EID: 33947691643     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi061359o     Document Type: Article

References (21)

1. Braak, H., and Braak, E. (1997) Frequency of stages of Alzheimer-related lesions in different age categories, Neurobiol. Aging 18, 351-357.
2. Lee, V. M., Goedert, M., and Trojanowski, J. Q. (2001) Neurodegenerative tauopathies, Annu. Rev. Neurosci. 24, 1121-1159.
3. Ihara, Y. (2001) PHF and PHF-like fibrils: Cause or consequence? Neurobiol. Aging 22, 123-126.
4. Reed, L. A., Wszolek, Z. K., and Hutton, M. (2001) Phenotypic correlations in FTDP-17, Neurobiol. Aging 22, 89-107.
5. Santacruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., Forster, C., Yue, M., Orne, J., Janus, C., Mariash, A., Kuskowski, M., Hyman, B., Hutton, M., and Ashe, K. H. (2005) Tau suppression in a neurodegenerative mouse model improves memory function, Science 309, 476-481.
6. Barghorn, S., and Mandelkow, E. (2002) Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments, Biochemistry 41, 14885-14896.
7. Hasegawa, M., Smith, M. J., and Goedert, M. (1998) Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly, FEBS Lett. 437, 207-210.
8. Friedhoff, P., Schneider, A., Mandelkow, E. M., and Mandelkow, E. (1998) Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution, Biochemistry 37, 10223-10230.
9. Yoshiike, Y., Tanemura, K., Murayama, O., Akagi, T., Murayama, M., Sato, S., Sun, X., Tanaka, N., and Takashima, A. (2001) New insights on how metals disrupt amyloid β-aggregation and their effects on amyloid-β cytotoxicity, J. Biol. Chem. 276, 32293-32299.
10. Maeda, S., Sahara, N., Saito, Y., Murayama, S., Ikai, A., and Takashima, A. (2006) Increased levels of granular tau oligomers: An early sign of brain aging and Alzheimer's disease, Neurosci. Res. 54, 197-201.
11. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis, Science 300, 486-489.
12. George, A., and Wilson, W. W. (1994) Predicting protein crystallization from a dilute solution property, Acta Crystallogr. D50, 361-365.
13. Schweers, O., Schonbrunn-Hanebeck, E., Marx, A., and Mandelkow, E. (1994) Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for β-structure, J. Biol. Chem. 269, 24290-24297.
14. Greenberg, S. G., and Davies, P. (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis, Proc. Natl. Acad. Sci. U.S.A. 87, 5827-5831.
15. Chirita, C. N., Congdon, E. E., Yin, H., and Kuret, J. (2005) Triggers of full-length tau aggregation: A role for partially folded intermediates, Biochemistry 44, 5862-5872.
16. Baskakov, I. V., Legname, G., Baldwin, M. A., Prusiner, S. B., and Cohen, F. E. (2002) Pathway complexity of prion protein assembly into amyloid, J. Biol. Chem. 277, 21140-21148.
17. Haroutunian, V., Davies, P., Vianna, C., Buxbaum, J. D., and Purohit, D. P. (2005) Tau protein abnormalities associated with the progression of alzheimer disease type dementia, Neurobiol. Aging (in press).
18. Tatebayashi, Y., Miyasaka, T., Chui, D. H., Akagi, T., Mishima, K., Iwasaki, K., Fujiwara, M., Tanemura, K., Murayama, M., Ishiguro, K., Planel, E., Sato, S., Hashikawa, T., and Takashima, A. (2002) Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau, Proc. Natl. Acad. Sci. U.S.A. 99, 13896-13901.
19. Tanemura, K., Akagi, T., Murayama, M., Kikuchi, N., Murayama, O., Hashikawa, T., Yoshiike, Y., Park, J. M., Matsuda, K., Nakao, S., Sun, X., Sato, S., Yamaguchi, H., and Takashima, A. (2001) Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau, Neurobiol. Dis. 8, 1036-1045.
20. Tanemura, K., Murayama, M., Akagi, T., Hashikawa, T., Tominaga, T., Ichikawa, M., Yamaguchi, H., and Takashima, A. (2002) Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau, J. Neurosci. 22, 133-141.
21. Brandt, R., Hundelt, M., and Shahani, N. (2005) Tau alteration and neuronal degeneration in tauopathies: Mechanisms and models, Biochim. Biophys. Acta 1739, 331-354.